News

  1. AI Agent Enhances Principal Investigator Oversight Of eCOA Data 2/3/2026

    Explore how AI agents are better assisting principal investigators with oversight of electronic clinical outcome assessment (eCOA) data.

  2. Medable Debuts AI Agent for Automating Trial Master File (TMF) Processes 2/3/2026

    Managing trial master files is often manual, time-consuming, and error-prone. Learn how AI agents can help automate TMF workflows and streamline clinical operations.

  3. Univo IRB And The Patient View Announce Partnership 1/28/2026

    Univo IRB today announced a partnership with The Patient View to provide essential patient insights that will improve clinical trial participation and retention for sponsors and CROs.

  4. Avance Clinical Launches Diversity In STEM Scholarships Across Australia And North America 12/22/2025

    Avance Clinical, the award-winning global CRO for biotechs, has announced the launch of its new Diversity in STEM Scholarships, a global initiative designed to support women and minority-group students pursuing careers in science, technology, engineering, and mathematics (STEM). The program includes dedicated intakes in Australia and the broader Asia-Pacific region, as well as North America, reinforcing the company’s commitment to equity and inclusion in clinical research.

  5. Lindus Health And Quotient Sciences Partner To Accelerate Drug Development From First-In-Human To Pivotal Trials 12/11/2025

    Lindus Health and Quotient Sciences partnership combines Quotient's specialized early clinical and drug development capabilities with Lindus’ proven patient recruitment expertise and later-stage trial delivery.

  6. Integrating Lyft Healthcare As An Affordable On-Demand Transportation Provider For Clinical Trial Participants: A Move Towards Enhanced Patient Experience 12/8/2025
  7. Yoncare s.r.o. Partners With Block Clinical Inc. To Deliver EU-Centric Clinical Trial Participant Travel And Payment Services In Europe 12/5/2025
  8. Block Clinical Discusses Patient Travel Support With Panel Members 12/5/2025
  9. Quotient Sciences And Intrepid Labs Form Strategic Partnership To Accelerate AI-Guided Formulation Development 12/4/2025

    Under the new agreement, Quotient Sciences will have access to Intrepid’s machine learning model, ANDROMEDA, the first AI platform to develop and optimize clinical performance of drug products. The platform is designed to significantly reduce formulation development timelines, reduce API demands and increase formulation understanding, helping clients reach critical milestones faster and improve confidence in clinical success.

  10. One App To Simplify The Clinical Trial Journey 11/12/2025

    Unified mobile app streamlines trial tasks—scheduling, questionnaires, travel, and reimbursements—reducing burden and improving engagement for patients and study teams.